Dihydroceramide Desaturase 1 Inhibitors Reduce Amyloid-β Levels in Primary Neurons from an Alzheimer’s Disease Transgenic Model

Ordóñez-Gutiérrez, LaraOrdóñez Gutiérrez, LaraBenito-Cuesta, IreneAbad, José LuisCasas, JosefinaFábrias, GemmaWandosell, Francisco2025-01-132025-01-132018Ordóñez-Gutiérrez L, Benito-Cuesta I, Abad JL, Casas J, Fábrias G, Wandosell F. Dihydroceramide Desaturase 1 Inhibitors Reduce Amyloid-β Levels in Primary Neurons from an Alzheimer's Disease Transgenic Model. Pharm Res. 2018 Feb 6;35(3):49. doi: 10.1007/s11095-017-2312-2. PMID: 29411122.0724-874110.1007/s11095-017-2312-2https://hdl.handle.net/20.500.14352/113870engAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/Dihydroceramide Desaturase 1 Inhibitors Reduce Amyloid-β Levels in Primary Neurons from an Alzheimer’s Disease Transgenic Modeljournal article1573-904Xhttps://doi.org/10.1007/s11095-017-2312-2open access616.894-053.9Alzheiemer's diseaseamyloid betaAPP/PS1autophagydihidroceramide desaturaseCiencias24 Ciencias de la Vida